TETERBORO, N.J., Feb 13, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic
testing, information and services, announced today that its Board of Directors
has elected James F. ("Jay") Flaherty III to serve as a Director, expanding the
Board to 12 members.
Mr. Flaherty, 45, is the President and Chief Operating Officer and a member of
the Board of Directors of Health Care Property Investors (NYSE: HCP), a
self-administered Equity Real Estate Investment Trust (REIT) that invests in
healthcare real estate properties and leases them to healthcare providers in the
U.S.
Prior to joining Health Care Property Investors (HCPI) in October 2002, Mr.
Flaherty served in a variety of investment banking, capital markets and private
equity functions at Merrill Lynch & Co. in its New York, London and Los Angeles
offices during his nineteen-year career with the company. As head of Merrill
Lynch's Global Healthcare Group, he was responsible for creating and leading
Merrill Lynch's healthcare practice.
"We are pleased that Jay Flaherty is joining the Board," said Kenneth W.
Freeman, Chairman and Chief Executive Officer of Quest Diagnostics. "Jay's
broad-based healthcare background and deep knowledge of corporate finance will
make him a valued addition to our Board."
Mr. Flaherty serves as a member of the College of Arts and Letters Advisory
Council for the University of Notre Dame and is a member of the Board of
Trustees for Catholic Charities of Los Angeles, Inc.
Quest Diagnostics Incorporated is the nation's leading provider of diagnostic
testing, information and services, providing insights that enable physicians,
hospitals, managed care organizations and other healthcare professionals to make
decisions to improve health. The company offers the broadest access to
diagnostic laboratory services through its national network of laboratories and
patient service centers. Quest Diagnostics is the leading provider of esoteric
testing, including gene-based medical testing, and empowers healthcare
organizations and clinicians with state-of-the-art connectivity solutions that
improve practice management. Additional company information can be found on the
Internet at: www.questdiagnostics.com.
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking statements
involve risks and uncertainties that could cause actual results and outcomes to
be materially different. Certain of these risks and uncertainties may include,
but are not limited to, unanticipated expenditures, changing relationships with
customers, suppliers and strategic partners, conditions of the economy and other
factors described in the Quest Diagnostics Incorporated 2001 Form 10-K and
subsequent filings.
SOURCE Quest Diagnostics Incorporated
CONTACT:
Investors - Laure Park, +1-201-393-5030, or Media - Gary
Samuels, +1-201-393-5700, both of Quest Diagnostics Incorporated
URL: http://www.questdiagnostics.com
Copyright (C) 2003 PR Newswire. All rights reserved.